Newsletter | May 9, 2025

05.09.25 -- PDG-FDA Town Hall Notes — DSCSA Readiness Is At Hand

SPONSOR

Discover the future of iPSC-based therapies in this free Cell & Gene Live digital event. Experts will share insights on emerging applications, regulatory challenges, gene editing advancements, and key safety considerations in scalable iPSC manufacturing. Don't miss this opportunity to hear from leaders at the forefront of regenerative medicine. Supported by Invetech.

FOCUS ON SUPPLY CHAIN

PDG-FDA Town Hall Notes — DSCSA Readiness Is At Hand

Data quality and exceptions handling were key discussion points during a March PDG-FDA town hall, where stakeholders shared updates on progress and unfinished work.

Navigating The Nuances Of Process And Analytical Development

This panel discussion explores the intricate challenges in transitioning cell therapy processes from research to Good Manufacturing Practice compliance.

New Container Protects Bulk Frozen Biopharmaceuticals

Learn more about a flexible freeze container that maintains package integrity after freezing at -86 °C. (-123 °F) through its durable design, minimizing product loss due to package failure.

The Rescue Option: Course Correcting Struggling Clinical Trials

The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.

SUPPLY CHAIN SOLUTIONS

Process Liquids And Buffers To Accelerate Your Speed-To-Market - Thermo Fisher Scientific

FOCUS ON CLINICAL TRIALS

Clinical Development Strategies And Prioritization For AAVs

In this segment of the Cell & Gene Live, Unlocking the Full Potential of AAV-Mediated Gene Delivery, David Dismuke, Ph.D., Chief Technical Officer, Forge Biologics and Nina Hunter, Ph.D., VP Corporate Strategy at REGENXBIO, the panelists discuss the overall clinical development strategy for AAV based gene therapies.

Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies

To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.

Consent By Proxy: The Key To More Inclusive, More Reliable Trials

Explore innovative digital workflow designed specifically for Legally Authorized Representative (LAR) to help overcome the challenges of complex documentation and data management issues.

Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology

Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.

What To Look For In An Oncology CRO

Learn seven of the critical factors for choosing an oncology-focused CRO that enable sponsors to identify partners aligning with their clinical research objectives.

Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments

A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.

CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs

Navigate the intricate regulatory landscape with knowledge that can help you move your CRISPR therapies quickly and efficiently through clinical trials.

CLINICAL TRIALS SOLUTIONS

Accelerating Biologics Through Development Milestones - Veristat, Inc.

Drug Development Experience For Biotechs - Avance Clinical

Liver Disease CRO Services - Novotech

Connect With Cell & Gene: